Lexicon Pharmaceuticals (LXRX)

• Market cap: $472M
• 1 day: -1.52%
• 5 days: -8.45%
• 1 month: -15.58%
• 3 months: 13.04%
• 6 months: 86.84%
• Year to date: 67.29%
• 1 year: 58.11%
• 5 years: -56.38%
• 10 years: -89.61%
• Sector: Healthcare
• Industry: Biotechnology

About: Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Employees: 103